The B.C. government has announced that long-term care residents and health-care workers will be the first to receive the vaccine next week. The vaccine comes in two doses meant to be administered three weeks apart. After the first dose, the efficacy is about 52 per cent; after the second, 95 per cent.that the vaccine worked regardless of race, weight or age. No one experienced any serious side-effects in the trial of 43,661 people from around the world but many experienced aches and fevers.
Acuitas was founded in 2009 by Thomas Madden, the company president and CEO, and his longtime collaborator, Pieter Cullis, board chairman and scientific adviser. Madden said that it was humbling to realize that Acuitas has played a role in delivering a COVID-19 vaccine.